Satoh 1995 Br J Pharmacol: Difference between revisions
(Created page with "{{Publication |title=Satoh K, Yamato A, Nakai T, Hoshi K, Ichihara K (1995) Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in ...") |
Gnaiger Caro (talk | contribs) No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{Publication | {{Publication | ||
|title=Satoh K, Yamato A, Nakai T, Hoshi K, Ichihara K (1995) Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in ischaemic dog hearts. Br J Pharmacol 116:1894- | |title=Satoh K, Yamato A, Nakai T, Hoshi K, Ichihara K (1995) Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in ischaemic dog hearts. Br J Pharmacol 116:1894-98. | ||
|info=[http://www.ncbi.nlm.nih.gov/pubmed/8528576 PMID:8528576] | |info=[http://www.ncbi.nlm.nih.gov/pubmed/8528576 PMID:8528576] | ||
|authors=Satoh K, Yamato A, Nakai T, Hoshi K, Ichihara K | |authors=Satoh K, Yamato A, Nakai T, Hoshi K, Ichihara K | ||
| Line 12: | Line 12: | ||
|organism=Dog | |organism=Dog | ||
|tissues=Heart | |tissues=Heart | ||
|preparations=Isolated | |preparations=Isolated mitochondria | ||
|injuries=Ischemia- | |injuries=Ischemia-reperfusion | ||
}} | }} | ||
Latest revision as of 09:12, 16 June 2015
| Satoh K, Yamato A, Nakai T, Hoshi K, Ichihara K (1995) Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in ischaemic dog hearts. Br J Pharmacol 116:1894-98. |
Satoh K, Yamato A, Nakai T, Hoshi K, Ichihara K (1995) Br J Pharmacol
Abstract: 1. Effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, pravastatin and simvastatin, on the myocardial level of coenzyme Q10, and on mitochondrial respiration were examined in dogs. 2. Either vehicle (control), pravastatin (4 mg kg-1 day-1), or simvastatin (2 mg kg-1 day-1) was administered orally for 3 weeks. First, the myocardial tissue level of coenzyme Q10 was determined in the 3 groups. Second, ischaemia was induced by ligating the left anterior descending coronary artery (LAD) in anaesthetized open chest dogs, pretreated with the inhibitors. After 30 min of ischaemia, nonischaemic and ischaemic myocardium were removed from the left circumflex and LAD regions, respectively, and immediately used for isolation of mitochondria. The mitochondrial respiration was determined by polarography, with glutamate and succinate used as substrates. 3. Simvastatin significantly decreased the myocardial level of coenzyme Q10, but pravastatin did not. 4. Ischaemia decreased the mitochondrial respiratory control index (RCI) in both groups. Significant differences in RCI between nonischaemic and ischaemic myocardium were observed in the control and simvastatin-treated groups. 5. Only in the simvastatin-treated group did ischaemia significantly decrease the ADP/O ratio, determined with succinate. 6. The present results indicate that simvastatin but not pravastatin may cause worsening of the myocardial mitochondrial respiration during ischaemia, probably because of reduction of the myocardial coenzyme Q10 level. • Keywords: 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors; ischaemic heart; mitochondria
Labels: MiParea: Respiration, mt-Medicine
Stress:Ischemia-reperfusion Organism: Dog Tissue;cell: Heart Preparation: Isolated mitochondria
